TREM2 and hepatocellular carcinoma: Interestingly, our analysis of RASF-MØ revealed an upregulation of TREM2, whose expression has been associated with a subset of macrophages with a proangiogenic and immunosuppressive profile in Hepatocellular Carcinoma patients [75].